Cargando…

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin

To study the mechanisms of the acute induction of drug resistance in cancer cells, we have established a model system in which adriamycin (ADM) induces immediate drug resistance. In this system, human colon carcinoma HT‐29 cells were pretreated for 1 h with a subtoxic dose of ADM (0.3 μg/ml) and inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomida, Akihiro, Naito, Mikihiko, Tsuruo, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920759/ https://www.ncbi.nlm.nih.gov/pubmed/7730148 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03043.x

Ejemplares similares

Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate
por: Ishida, Hiroyuki, et al.
Publicado: (1994)

Expression of 85‐kDa Protein of Adriamycin‐resistant Tumor Cells during Hematopoietic Differentiation of THP‐1 and HEL Cells
por: Ishii, Shigetaka, et al.
Publicado: (1992)

Expression Behavior of 85‐kDa Membrane Protein in Adriamycin‐resistant Tumor Cells and the Inhibition of Human Tumor Growth in Athymic Mice by MRK‐20 Monoclonal Antibody against the Protein
por: Ishii, Shigetaka, et al.
Publicado: (1993)

Inhibitory Effect of ATF3 Antisense Oligonucleotide on Ectopic Growth of HT29 Human Colon Cancer Cells
por: Ishiguro, Tatsuaki, et al.
Publicado: (2000)

A Novel Mutant from Apoptosis‐resistant Colon Cancer HT‐29 Cells Showing Hyper‐apoptotic Response to Hypoxia, Low Glucose and Cisplatin
por: Suzuki, Hiroyuki, et al.
Publicado: (1998)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐Diaphorase
por: Mikami, Koji, et al.
Publicado: (1998)

Enhancement of Reversing Effect of Cyclosporin A on Vincristine Resistance by Anti‐P‐glycoprotein Monoclonal Antibody MRK‐16
por: Naito, Mikihiko, et al.
Publicado: (1993)

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
por: Carmo-Pereira, J., et al.
Publicado: (1987)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Specific Reduction of Toxic Side Effects of Adriamycin by Induction of Metallothionein in Mice
por: Naganuma, Akira, et al.
Publicado: (1988)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Immunocytochemical Identification and Localization of the Mr 22,000 Calcium‐binding Protein (Sorcin) in an Adriamycin‐resistant Myelogenous Leukemia Cell Line
por: Sugawara, Isamu, et al.
Publicado: (1989)

Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.
por: Aitchison, R. G., et al.
Publicado: (1990)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
por: Manh Hung, Le Van, et al.
Publicado: (2018)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Cellular and Tissue Distribution of MRK20 Murine Monoclonal Antibody‐defined 85‐kDa Protein in Adriamycin‐resistant Cancer Cell Lines
por: Sugawara, Isamu, et al.
Publicado: (1988)

NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
por: de Jong, S., et al.
Publicado: (1991)

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

A Sarcoma at the Site of Previous Extravasation of Adriamycin
por: Ceulemans, Joris, et al.
Publicado: (2002)

An in vivo assessment of adriamycin-loaded albumin microspheres.
por: Goldberg, J. A., et al.
Publicado: (1992)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Effects of Methylxanthine Derivatives on Adriamycin Concentration and Antitumor Activity
por: Sadzuka, Yasuyuki, et al.
Publicado: (1995)

In vivo tumour-cell proliferation after adriamycin treatment.
por: Rowley, R., et al.
Publicado: (1982)

The effect of digoxin on the binding of adriamycin to cat heart muscle.
por: Somberg, J., et al.
Publicado: (1977)

Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
por: Allen, Barrett D., et al.
Publicado: (2019)

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats
por: Zhang, Wei, et al.
Publicado: (2008)

Artemether ameliorates adriamycin induced cardiac atrophy in mice
por: Weng, Wenci, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sjcukvcodcvnphrusr9q6scl6e